Inactive Instrument
Enzymatica AB Share Price Nasdaq Stockholm
Stocks
SE0003943620
Pharmaceuticals
OTC Markets Traded| Market Cap | 456M 401M 373M 342M 643M 43.95B 653M 4.43B 1.73B 21.61B 1.71B 1.68B 74.7B | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 424M 373M 347M 318M 597M 40.85B 607M 4.11B 1.61B 20.09B 1.59B 1.56B 69.44B | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.32% |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 31/01/2026 |
Ulf Thomas Blom
COO | Chief Operating Officer | 61 | 31/12/2010 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 12/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Bengt Baron
CHM | Chairman | 64 | 18/12/2016 |
| Chairman | 58 | 14/02/2016 | |
| Director/Board Member | 59 | 30/04/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.32% | +3.00% | - | - | 47.05M | |
| +0.86% | +1.43% | +47.17% | +161.40% | 1,067B | |
| +1.59% | +4.09% | +56.51% | +52.79% | 635B | |
| +0.95% | +1.91% | +36.30% | +83.13% | 458B | |
| +1.60% | +6.25% | +37.00% | +30.00% | 347B | |
| -0.60% | +1.52% | +36.67% | +39.80% | 295B | |
| -0.14% | +0.60% | +17.29% | +18.19% | 262B | |
| +0.09% | -2.82% | -29.09% | -41.29% | 216B | |
| +1.22% | +2.66% | +22.66% | +59.81% | 203B | |
| -1.18% | -3.70% | +11.28% | +67.43% | 161B | |
| Average | +0.67% | +1.33% | +26.20% | +52.36% | 404.83B | |
| Weighted average by Cap. | +0.76% | +1.95% | +35.99% | +78.15% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 45.58M 40.03M 37.23M 34.16M 64.18M 4.39B 65.17M 442M 173M 2.16B 171M 167M 7.46B | 53.9M 47.34M 44.03M 40.4M 75.91M 5.19B 77.08M 523M 204M 2.55B 202M 198M 8.82B |
| Net income | -53.18M -46.71M -43.44M -39.86M -74.89M -5.12B -76.05M -516M -202M -2.52B -200M -195M -8.71B | -51.89M -45.57M -42.38M -38.89M -73.08M -5B -74.2M -503M -197M -2.46B -195M -191M -8.49B |
| Net Debt | -73.01M -64.13M -59.64M -54.72M -103M -7.03B -104M -708M -277M -3.46B -274M -268M -11.95B | -32.11M -28.2M -26.23M -24.07M -45.22M -3.09B -45.92M -311M -122M -1.52B -121M -118M -5.26B |
Employees
-
Sector
Pharmaceuticals
Calendar
